Last update July 1, 2015

Rifaximin

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Antibiótico derivado de la rifamicina, no aborbible, utilizado por vía oral para tratar determinadas diarreas y afecciones intestinales.

A fecha de última actualización no encontramos datos publicados en relación con la lactancia pero su falta casi absoluta de absorción intestinal (< 1%) y su elevado peso molecular hacen muy improbable su paso a leche. Por otra parte sus posibles efectos secundarios son leves y casi limitados a molestias abdominales.

Alternatives

We do not have alternatives for Rifaximin since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Rifaximin is also known as


Rifaximin in other languages or writings:

Group

Rifaximin belongs to this group or family:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. < 0.4 %
Molecular weight 786 daltons
Protein Binding 68 %

References

  1. PDR.net Rifaximin Drug Summary 2014 Full text (in our servers)
  2. Alfa Wassermann Rifaximina Ficha técnica 2011 Full text (in our servers)
  3. Chen LH, Zeind C, Mackell S, LaPointe T, Mutsch M, Wilson ME. Breastfeeding travelers: precautions and recommendations. J Travel Med. 2010 Jan-Feb;17(1):32-47. Abstract Full text (link to original source) Full text (in our servers)
  4. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul;131(1):283-311. Review. Abstract Full text (link to original source) Full text (in our servers)

Total visits

33,923

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM